CFIUS and Foreign Investment Reviews

When your transaction involves a foreign investment in a U.S. business, you need guidance to assess the national security implications of the transaction.

We advise U.S. companies, foreign multinationals, venture capitalists, and global private equity investors, including those from sensitive countries, on national security reviews before the Committee on Foreign Investment in the United States (CFIUS) and foreign investment regulators on a global basis.

Our team includes former government lawyers who understand the opaque inner-workings of CFIUS.

You take matters of national security seriously. So do we. Safeguard your transactions, investments, and business with us.

International Trade & Investment

Export Controls

Sanctions

Operating in today’s global marketplace means addressing a full range of international trade and investment matters.

Learn more

Staying ahead of global export controls enforcement? One matter can trigger laws in many countries. What are your risks?

Learn more

We help you navigate the minefield of sanctions and export controls compliance. Our team at Hogan Lovells operates seamlessly across all jurisdictions and industries to provide you with comprehensive and practical advice. Sanctions can be imposed without notice. That's why we monitor developments and provide insight into the possible interpretations of new sanctions.

Learn more

Key contacts

Brian P. Curran

Partner

Brian P. Curran

Partner

Washington, D.C.

Anne Salladin

Senior Counsel

Anne Salladin

Senior Counsel

Washington, D.C.

Anthony V. Capobianco

Partner

Anthony V. Capobianco

Partner

Washington, D.C.

Meet the CFIUS and Foreign Investment Reviews team

Representative experience

Secure CFIUS clearance for ALSTOM in the US$12.4bn sale of its thermal power, renewable power, and grid businesses to GE.

Provide CFIUS advice to Chinese technology company Unisplendour concerning its contemplated investment in Western Digital Corp.

Secure CFIUS clearance for Dell, Inc. regarding the US$3bn sale of its IT services business to Japanese company NTT.

Secure CFIUS approval for the sale of certain assets of General Dynamics Advanced Information Systems, Inc. subsidiary to Canadian company MacDonald, Dettwiler and Associates Ltd.

You may also be interested in...

Media mention

Interview: Global Head of M&A Bill Curtin – CNBC "Money Movers”

22 December 2025

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from the U.S. navigate through it?

Webinar

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from the U.S. navigate through it?

26 September 2023 | 5:00 PM - 6:00 PM (CEST)

Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on The U.S. - Session 1

Webinar

Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on The U.S. - Session 1

14 September 2023 | 10:00 a.m. - 11:00 a.m. (CST) | 11:00 a.m. - 12:00 p.m. (JST) | 12:00 p.m. - 1:00 p.m. (AEST) | 10:00 p.m. - 11:00 p.m. EDT (Wednesday, 13 September 2023)

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from Asia navigate through it?

Hogan Lovells Events

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from Asia navigate through it?

20 June 2023 | 9:30 a.m. - 10:30 a.m. (CEST)

M&A: The new ways CFIUS is approaching national security with a focus on multiple acquisitions or investments

Sponsorships and Speaking Engagements

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from the U.S. navigate through it?

Webinar

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from the U.S. navigate through it?

26 September 2023 | 5:00 PM - 6:00 PM (CEST)

Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on The U.S. - Session 1

Webinar

Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on The U.S. - Session 1

14 September 2023 | 10:00 a.m. - 11:00 a.m. (CST) | 11:00 a.m. - 12:00 p.m. (JST) | 12:00 p.m. - 1:00 p.m. (AEST) | 10:00 p.m. - 11:00 p.m. EDT (Wednesday, 13 September 2023)

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from Asia navigate through it?

Hogan Lovells Events

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from Asia navigate through it?

20 June 2023 | 9:30 a.m. - 10:30 a.m. (CEST)

M&A: The new ways CFIUS is approaching national security with a focus on multiple acquisitions or investments

Sponsorships and Speaking Engagements

Digital Client Solutions

Empowering you to lead change through our digital solutions.

Learn more

Insights and Analysis

CFIUS and Foreign Investment Reviews

When your transaction involves a foreign investment in a U.S. business, you need guidance to assess the national security implications of the transaction.

Explore our capabilites

International Trade & Investment

Export Controls

Sanctions

Key contacts

Representative experience

You may also be interested in...

Interview: Global Head of M&A Bill Curtin – CNBC "Money Movers”

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from the U.S. navigate through it?

Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on The U.S. - Session 1

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from Asia navigate through it?

M&A: The new ways CFIUS is approaching national security with a focus on multiple acquisitions or investments

Anne Salladin named to Foreign Investment Watch's Top Advisors 2023 List

Hogan Lovells named to Foreign Investment Watch’s “Founding Advisors” List

Anne Salladin named to Foreign Investment Watch's Top Advisors 2022 List

Anne Salladin named to Foreign Investment Watch's Top Advisors 2022 List

Anne Salladin named to Foreign Investment Watch’s Top Advisors 2021 List

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from the U.S. navigate through it?

Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on The U.S. - Session 1

The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from Asia navigate through it?

M&A: The new ways CFIUS is approaching national security with a focus on multiple acquisitions or investments

Interview: Global Head of M&A Bill Curtin – CNBC "Money Movers”

Anne Salladin named to Foreign Investment Watch's Top Advisors 2023 List

Hogan Lovells named to Foreign Investment Watch’s “Founding Advisors” List

Anne Salladin named to Foreign Investment Watch's Top Advisors 2022 List

Anne Salladin named to Foreign Investment Watch's Top Advisors 2022 List

Anne Salladin named to Foreign Investment Watch’s Top Advisors 2021 List